Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells

T Nakaki, M Nakayama, S Yamamoto and R Kato

Department of Pharmacology, Keio University School of Medicine, Tokyo, Japan.

Effects of catecholamines on DNA synthesis in vascular smooth muscle cells (VSMC) were investigated in a chemically defined medium that included insulin, transferrin, and sodium selenite. Smooth muscle-rich preparation was obtained from rat aortic media and VSMC were further purified by cell cloning. A clone that was positive for smooth muscle actin and was negative for the coagulation factor VIII was used in this study. The fetal calf serum-induced proliferation was enhanced by alpha- adrenergic and inhibited by beta-adrenergic stimulation. When cells of low passages were used, dose-response curves for norepinephrine were biphasic; when cells were subconfluent, norepinephrine stimulated DNA synthesis at as low as 1 nM and was apparently ineffective at more than 100 nM. When cells were confluent, the effect of norepinephrine was inhibitory at lower concentrations (less than 1 nM) and stimulatory at relatively higher concentrations. Cells of higher passages exhibited only inhibitory effects of the amine. Stimulatory and inhibitory effects on DNA synthesis were mediated through alpha 1- and beta 2- adrenergic receptors, respectively. Thus, the alpha 1-agonist phenylephrine was more potent than the alpha 2-agonist clonidine in stimulating DNA synthesis. An alpha 1-adrenergic antagonist, prazosin, was more effective than the alpha 2-adrenergic antagonist yohimbine in antagonizing the stimulatory effect of norepinephrine. beta-Adrenergic agonists inhibited DNA synthesis with IC50 values in the nanomolar range; the rank order of potency of agonists was isoproterenol greater than salbutamol greater than or equal to (-)-epinephrine much greater than (-)-norepinephrine, consistent with beta 2-receptor specificity. (+)-Epinephrine or (+)-norepinephrine, the stereoisomers of the catecholamines, were ineffective. The inhibitory effects of norepinephrine were reversed by beta-adrenergic antagonists, with the rank order of potency of pindolol greater than butoxamine greater than atenolol, consistent with beta 2-receptor specificity. The dose- response curves of norepinephrine, therefore, seemed to be determined by a balance between alpha 1-receptor-mediated stimulation and beta 2- receptor-mediated inhibition of DNA synthesis. Minimum time required for exhibiting alpha 1-adrenergic or beta 2-adrenergic effects was between 6 and 15 hr, suggesting that the G0 or G1 phase of the cell cycle might be the site of action. These results show that catecholamines dually modulate DNA synthesis in VSMC through specific adrenergic receptors.

Volume 37, Issue 1, pp. 30-36, 01/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				G. Bernini, F. Franzoni, F. Galetta, A. Moretti, C. Taurino, M. Bardini, G. Santoro, L. Ghiadoni, M. Bernini, and A. Salvetti Carotid Vascular Remodeling in Patients with Pheochromocytoma J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1754 - 1760. [Abstract] [Full Text] [PDF]

				R. Gros, Q. Ding, J. Chorazyczewski, J. Andrews, J. G. Pickering, R. A. Hegele, and R. D. Feldman The Impact of Blunted beta-Adrenergic Responsiveness on Growth Regulatory Pathways in Hypertension Mol. Pharmacol., January 1, 2006; 69(1): 317 - 327. [Abstract] [Full Text] [PDF]

				D. H. Damon Sympathetic innervation promotes vascular smooth muscle differentiation Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2785 - H2791. [Abstract] [Full Text] [PDF]

				P. M. Ullrich, S. K. Lutgendorf, J. Leserman, D. G. Turesky, and K. J. Kreder Stress, Hostility, and Disease Parameters of Benign Prostatic Hyperplasia Psychosom Med, May 1, 2005; 67(3): 476 - 482. [Abstract] [Full Text] [PDF]

				P. J. Gonzalez-Cabrera, T. Shi, J. Yun, D. F. McCune, B. R. Rorabaugh, and D. M. Perez Differential Regulation of the Cell Cycle by {alpha}1-Adrenergic Receptor Subtypes Endocrinology, November 1, 2004; 145(11): 5157 - 5167. [Abstract] [Full Text] [PDF]

				R. K. Dubey, E. K. Jackson, D. G. Gillespie, L. C. Zacharia, and B. Imthurn Catecholamines Block the Antimitogenic Effect of Estradiol on Human Coronary Artery Smooth Muscle Cells J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3922 - 3931. [Abstract] [Full Text] [PDF]

				C. V. Remillard and J. X.-J. Yuan Activation of K+ channels: an essential pathway in programmed cell death Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L49 - L67. [Abstract] [Full Text] [PDF]

				R. K. Dubey, L. C. Zacharia, D. G. Gillespie, B. Imthurn, and E. K. Jackson Catecholamines Block the Antimitogenic Effect of Estradiol on Human Glomerular Mesangial Cells Hypertension, September 1, 2003; 42(3): 349 - 355. [Abstract] [Full Text] [PDF]

				J.-H. Parmentier, P. Smelcer, Z. Pavicevic, E. Basic, A. Idrizovic, A. Estes, and K. U. Malik PKC-{zeta} Mediates Norepinephrine-Induced Phospholipase D Activation and Cell Proliferation in VSMC Hypertension, March 1, 2003; 41(3): 794 - 800. [Abstract] [Full Text] [PDF]

				C. Hague, P. J. Gonzalez-Cabrera, W. B. Jeffries, and P. W. Abel Relationship between alpha 1-Adrenergic Receptor-Induced Contraction and Extracellular Signal-Regulated Kinase Activation in the Bovine Inferior Alveolar Artery J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 403 - 411. [Abstract] [Full Text] [PDF]

				L. C. Zacharia, E. K. Jackson, D. G. Gillespie, and R. K. Dubey Catecholamines Block 2-Hydroxyestradiol-Induced Antimitogenesis in Mesangial Cells Hypertension, April 1, 2002; 39(4): 854 - 859. [Abstract] [Full Text] [PDF]

				L. C. Zacharia, E. K. Jackson, D. G. Gillespie, and R. K. Dubey Catecholamines Abrogate Antimitogenic Effects of 2-Hydroxyestradiol on Human Aortic Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1745 - 1750. [Abstract] [Full Text] [PDF]

				B. C. Berk Vascular Smooth Muscle Growth: Autocrine Growth Mechanisms Physiol Rev, July 1, 2001; 81(3): 999 - 1030. [Abstract] [Full Text] [PDF]

				J. Varagic, D. Susic, and E. D. Frohlich Cardiovasc Pharmacol Therapeut 6(1):57-63, 2001 Low-Dose ACE with Alphaor Beta-Adrenergic Receptor Inhibitors Have Beneficial SHR Cardiovascular Effects Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 57 - 63. [Abstract] [PDF]

				N. Kyprianou and C. M. Benning Suppression of Human Prostate Cancer Cell Growth By {{alpha}}1-Adrenoceptor Antagonists Doxazosin and Terazosin via Induction of Apoptosis Cancer Res., August 1, 2000; 60(16): 4550 - 4555. [Abstract] [Full Text]

				D. H. Damon VSM growth is stimulated in sympathetic neuron/VSM cocultures: role of TGF-beta 2 and endothelin Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H404 - H411. [Abstract] [Full Text] [PDF]

				M. J. Zuscik, M. T. Piascik, and D. M. Perez Cloning, Cell-Type Specificity, and Regulatory Function of the Mouse alpha 1B-Adrenergic Receptor Promoter Mol. Pharmacol., December 1, 1999; 56(6): 1288 - 1297. [Abstract] [Full Text]

				Z.-W. Hu, X.-Y. Shi, R. Z. Lin, J. Chen, and B. B. Hoffman alpha 1-Adrenergic Receptor Stimulation of Mitogenesis in Human Vascular Smooth Muscle Cells: Role of Tyrosine Protein Kinases and Calcium in Activation of Mitogen-Activated Protein Kinase J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 28 - 37. [Abstract] [Full Text]

				J. Chen, R. Lin, Z.-W. Hu, and B. B. Hoffman alpha 1-Adrenergic Receptor Activation of c-fos Expression in Transfected Rat-1 Fibroblasts: Role of Ca2+  J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1376 - 1384. [Abstract] [Full Text]

				S. S. Salvi {alpha}1-Adrenergic Hypothesis for Pulmonary Hypertension Chest, June 1, 1999; 115(6): 1708 - 1719. [Abstract] [Full Text] [PDF]

				R. Z. Lin, J. Chen, Z.-W. Hu, and B. B. Hoffman Phosphorylation of the cAMP Response Element-binding Protein and Activation of Transcription by alpha 1 Adrenergic Receptors J. Biol. Chem., November 6, 1998; 273(45): 30033 - 30038. [Abstract] [Full Text] [PDF]

				M. R. Uddin, M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik Cytochrome P-450 Metabolites Mediate Norepinephrine-Induced Mitogenic Signaling Hypertension, January 1, 1998; 31(1): 242 - 247. [Abstract] [Full Text] [PDF]

				K. Yasunari, M. Kohno, T. Hasuma, T. Horio, H. Kano, K. Yokokawa, M. Minami, and J. Yoshikawa Dopamine as a Novel Antimigration and Antiproliferative Factor of Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3164 - 3173. [Abstract] [Full Text]

				X. Xin, N. Yang, A. D. Eckhart, and J. E. Faber alpha 1D-Adrenergic Receptors and Mitogen-Activated Protein Kinase Mediate Increased Protein Synthesis by Arterial Smooth Muscle Mol. Pharmacol., May 1, 1997; 51(5): 764 - 775. [Abstract] [Full Text]

				D. deBlois, S.M. Schwartz, E.M. van Kleef, J.E. Su, K.A. Griffin, A.K. Bidani, M.J.A.P. Daemen, and D.M. Lombardi Chronic {alpha}1-Adrenoreceptor Stimulation Increases DNA Synthesis in Rat Arterial Wall: Modulation of Responsiveness After Vascular Injury Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1122 - 1129. [Abstract] [Full Text]

				S.-M. Yu, S.-Y. Tsai, J.-H. Guh, F.-N. Ko, C.-M. Teng, and J. T. Ou Mechanism of Catecholamine-Induced Proliferation of Vascular Smooth Muscle Cells Circulation, August 1, 1996; 94(3): 547 - 554. [Abstract] [Full Text]

				Z.-W. Hu, X.-Y. Shi, R. Z. Lin, and B. B. Hoffman alpha(1)Adrenergic Receptors Activate Phosphatidylinositol 3-Kinase in Human Vascular Smooth Muscle Cells J. Biol. Chem., April 12, 1996; 271(15): 8977 - 8982. [Abstract] [Full Text] [PDF]

				T. Marumo, T. Nakaki, K. Hishikawa, H. Suzuki, R. Kato, and T. Saruta Cyclosporin A Inhibits Nitric Oxide Synthase Induction in Vascular Smooth Muscle Cells Hypertension, April 1, 1995; 25(4): 764 - 768. [Abstract] [Full Text]

				M. J. Zuscik, D. Chalothorn, D. Hellard, C. Deighan, A. McGee, C. J. Daly, D. J. J. Waugh, S. A. Ross, R. J. Gaivin, A. J. Morehead, et al. Hypotension, Autonomic Failure, and Cardiac Hypertrophy in Transgenic Mice Overexpressing the alpha 1B-Adrenergic Receptor J. Biol. Chem., April 20, 2001; 276(17): 13738 - 13743. [Abstract] [Full Text] [PDF]

				H. Zhang and J. E. Faber Trophic Effect of Norepinephrine on Arterial Intima-Media and Adventitia Is Augmented by Injury and Mediated by Different {alpha}1-Adrenoceptor Subtypes Circ. Res., October 26, 2001; 89(9): 815 - 822. [Abstract] [Full Text] [PDF]